John A Olschowka Selected Research

John A Olschowka Research Topics

Disease

14	Neuroinflammatory Diseases 02/2022 - 02/2004
10	Inflammation (Inflammations) 02/2022 - 01/2002
7	Alzheimer Disease (Alzheimer's Disease) 06/2023 - 03/2012
4	Amyloid Plaque 02/2022 - 09/2014
3	Cognitive Dysfunction 12/2023 - 06/2013
3	Neoplasms (Cancer) 12/2019 - 10/2011
3	Encephalitis (Encephalitis, Rasmussen) 08/2012 - 08/2002
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2013 - 08/2002
2	Sandhoff Disease (Sandhoff's Disease) 08/2012 - 02/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2012 - 07/2010
1	Central Nervous System Diseases (CNS Diseases) 02/2022
1	Multiple Sclerosis 01/2021
1	Brain Neoplasms (Brain Tumor) 04/2020
1	Dementia (Dementias) 04/2019
1	Burns 10/2013
1	MYD88 Deficiency 08/2013
1	Arthritis (Polyarthritis) 04/2006
1	Pain (Aches) 04/2006
1	Infections 03/2006
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 02/2005
1	Pathologic Processes 02/2004
1	Edema (Dropsy) 02/2004
1	Brain Edema (Cerebral Edema) 02/2004
1	Radiation Injuries (Radiation Sickness) 08/2002
1	Brain Injuries (Brain Injury) 01/2002

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2012
7	CytokinesIBA 04/2019 - 07/2010
4	Proteins (Proteins, Gene)FDA Link 11/2015 - 02/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2006 - 01/2002
3	Interleukin-1beta (Interleukin 1 beta)IBA 09/2014 - 04/2006
2	Glatiramer Acetate (Copaxone)FDA Link 06/2023 - 01/2021
2	ChemokinesIBA 04/2019 - 03/2012
2	Interleukin-1 (Interleukin 1)IBA 08/2013 - 03/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2013 - 08/2002
2	InterleukinsIBA 03/2012 - 07/2010
2	Dinoprostone (PGE2)FDA Link 05/2005 - 01/2002
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2005 - 01/2002
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 02/2004 - 08/2002
2	ProstaglandinsIBA 02/2004 - 01/2002
1	Indicators and Reagents (Reagents)IBA 12/2023
1	Complement Receptors (Complement Receptor)IBA 12/2023
1	Phosphotransferases (Kinase)IBA 02/2022
1	c-Mer Tyrosine KinaseIBA 02/2022
1	LigandsIBA 02/2022
1	tyrosine receptor (receptor, tyrosine)IBA 02/2022
1	Protons (Proton)IBA 11/2020
1	SiliconIBA 11/2020
1	IronIBA 11/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Complement System Proteins (Complement)IBA 12/2019
1	Complementary DNA (cDNA)IBA 11/2015
1	Amyloid beta-PeptidesIBA 11/2015
1	RNA (Ribonucleic Acid)IBA 11/2015
1	ArginaseIBA 11/2015
1	Methamphetamine (Desoxyn)FDA LinkGeneric 09/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015
1	Congo RedIBA 09/2014
1	antineoplaston A10 (A 10)IBA 10/2013
1	NestinIBA 08/2013
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 06/2013
1	GangliosidesIBA 08/2012
1	Hexosaminidases (Hexosaminidase)IBA 08/2012
1	Cholinergic Agents (Cholinergics)IBA 03/2012
1	Cre recombinaseIBA 02/2012
1	Prostaglandins EIBA 07/2010
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2006
1	Calcitonin Gene-Related PeptideIBA 04/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2006
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 04/2006
1	Morphine (MS Contin)FDA LinkGeneric 03/2006
1	beta-N-AcetylhexosaminidasesIBA 02/2005
1	EnzymesIBA 02/2004
1	Protein Isoforms (Isoforms)IBA 02/2004
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2004
1	SteroidsIBA 02/2004
1	Messenger RNA (mRNA)IBA 08/2002

Therapy/Procedure

5	Therapeutics 12/2023 - 01/2002
4	Radiotherapy 02/2016 - 05/2005
3	Immunomodulation 01/2021 - 03/2013
3	Cranial Irradiation 04/2020 - 10/2011
2	Injections 11/2015 - 02/2003
1	Cannula 11/2015
1	Synchrotrons 01/2013